IN2012DE00794A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DE00794A IN2012DE00794A IN794DE2012A IN2012DE00794A IN 2012DE00794 A IN2012DE00794 A IN 2012DE00794A IN 794DE2012 A IN794DE2012 A IN 794DE2012A IN 2012DE00794 A IN2012DE00794 A IN 2012DE00794A
- Authority
- IN
- India
- Prior art keywords
- liphagane
- meroterpenoid
- scaffold
- anticancer activity
- pi3k
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The analogs of meroterpenoid liphagane scaffold have been designed, synthesized and its biological evaluation results for anticancer activity by inhibiting PI3K pathway is presented in this invention. The field of invention for this work relates and covers the development of novel PI3K-α/ß inhibitors based on meroterpenoid liphagane scaffold for anticancer activity.
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/385,808 US9206201B2 (en) | 2012-03-19 | 2013-03-18 | Boronic acid bearing liphagane compounds as inhibitors of P13K-α and/or β |
| CA2867452A CA2867452C (en) | 2012-03-19 | 2013-03-18 | Boronic acid bearing liphagane compounds as inhibitors of pi3k-.alpha. and/or .beta. |
| CN201380026291.5A CN104395325B (en) | 2012-03-19 | 2013-03-18 | With the LIPHAGANE compound of boric acid as the inhibitor of PI3K-α and/or β |
| JP2015501053A JP6126197B2 (en) | 2012-03-19 | 2013-03-18 | Rifagain compound with boronic acid as an inhibitor of PI3K-α and / or β |
| IN794DE2012 IN2012DE00794A (en) | 2012-03-19 | 2013-03-18 | |
| EP13723567.7A EP2828269B1 (en) | 2012-03-19 | 2013-03-18 | Boronic acid bearing liphagane compounds as inhibitors of pi3k-alpha and/or beta |
| PCT/IN2013/000169 WO2013140417A1 (en) | 2012-03-19 | 2013-03-18 | BORONIC ACID BEARING LIPHAGANE COMPOUNDS AS INHIBITORS OF PI3K-α AND/OR β |
| TW102109708A TWI577687B (en) | 2012-03-19 | 2013-03-19 | Boronic acid bearing liphagane compounds as inhibitors of pi3k-α and/or β |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN794DE2012 IN2012DE00794A (en) | 2012-03-19 | 2013-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DE00794A true IN2012DE00794A (en) | 2015-08-21 |
Family
ID=48464053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN794DE2012 IN2012DE00794A (en) | 2012-03-19 | 2013-03-18 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9206201B2 (en) |
| EP (1) | EP2828269B1 (en) |
| JP (1) | JP6126197B2 (en) |
| CN (1) | CN104395325B (en) |
| CA (1) | CA2867452C (en) |
| IN (1) | IN2012DE00794A (en) |
| TW (1) | TWI577687B (en) |
| WO (1) | WO2013140417A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3199090B2 (en) | 1993-10-19 | 2001-08-13 | 東芝ライテック株式会社 | Discharge lamp lighting device |
| WO2018203564A1 (en) | 2017-05-02 | 2018-11-08 | 国立大学法人東北大学 | Liphagal analog and multi-targeted kinase inhibitor containing liphagal or analog thereof |
| JP2019099537A (en) * | 2017-12-07 | 2019-06-24 | コニカミノルタ株式会社 | Method for producing nitrogen-containing heterocyclic compound |
| WO2024222697A1 (en) * | 2023-04-23 | 2024-10-31 | 纽欧申医药(上海)有限公司 | Nitrogen-containing polycyclic compound, and preparation method therefor and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006081659A1 (en) * | 2005-02-01 | 2006-08-10 | The University Of British Columbia | Meroterpenoid inhibitors of phosphoinositide 3 kinase (pi3k) |
| GB2465405A (en) * | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
-
2013
- 2013-03-18 EP EP13723567.7A patent/EP2828269B1/en not_active Not-in-force
- 2013-03-18 US US14/385,808 patent/US9206201B2/en active Active
- 2013-03-18 WO PCT/IN2013/000169 patent/WO2013140417A1/en not_active Ceased
- 2013-03-18 CA CA2867452A patent/CA2867452C/en active Active
- 2013-03-18 CN CN201380026291.5A patent/CN104395325B/en active Active
- 2013-03-18 IN IN794DE2012 patent/IN2012DE00794A/en unknown
- 2013-03-18 JP JP2015501053A patent/JP6126197B2/en active Active
- 2013-03-19 TW TW102109708A patent/TWI577687B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| US9206201B2 (en) | 2015-12-08 |
| CA2867452A1 (en) | 2013-09-26 |
| CA2867452C (en) | 2020-04-14 |
| CN104395325B (en) | 2016-12-07 |
| EP2828269A1 (en) | 2015-01-28 |
| JP2015514701A (en) | 2015-05-21 |
| TWI577687B (en) | 2017-04-11 |
| WO2013140417A4 (en) | 2013-11-21 |
| JP6126197B2 (en) | 2017-05-10 |
| EP2828269B1 (en) | 2018-05-16 |
| WO2013140417A1 (en) | 2013-09-26 |
| TW201341391A (en) | 2013-10-16 |
| US20150051173A1 (en) | 2015-02-19 |
| CN104395325A (en) | 2015-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502141A1 (en) | Compounds and their methods of use | |
| TN2014000138A1 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
| UA111386C2 (en) | PYRIDOPIRASES THAT HAVE ANTI-CANCER ACTIVITY THROUGH FGFR-KINAS INHIBITION | |
| TR201816379T4 (en) | DNA-PK inhibitors. | |
| PH12015500064B1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
| IN2014DN10670A (en) | ||
| GEP201706624B (en) | Triazolopyrazine as brd4 inhibitors and usage thereof for cancer treatment | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| GEP201706688B (en) | Cdk8/cdk19 selective inhibitors and their use in anti- metastatic and chemopreventative methods for cancer | |
| EA201490423A1 (en) | METHODS AND COMPOSITIONS RELATED TO p62 FOR TREATMENT AND PREVENTION OF CANCER | |
| IN2014KN02906A (en) | ||
| GEP201706623B (en) | Pyrrolotriazinone derivatives as pi3k inhibitors | |
| UA111744C2 (en) | REPLACED PYRIDOPORASINS AS SYK INHIBITORS | |
| MX2014014832A (en) | Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase. | |
| MX2014012477A (en) | Pyrrolopyrazone inhibitors of tankyrase. | |
| PH12014501032A1 (en) | 2-thiopyrimidinones | |
| GEP201706687B (en) | Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme | |
| MX363551B (en) | Pyrazine kinase inhibitors. | |
| MX370253B (en) | Compositions of jasmonate compounds and methods of use. | |
| PH12015501175A1 (en) | Substituted pyridopyrazines as syk inhibitors | |
| MX351863B (en) | Quinolylpyrrolopyrimidyl fused-ring compound or salt thereof. | |
| TN2012000469A1 (en) | Use of novel pan-cdk inhibitors for treating tumors | |
| WO2013052108A3 (en) | Methods and compositions for the treatment and diagnosis of ovarian cancer | |
| IN2012DE00794A (en) | ||
| IN2015DN00950A (en) |